The alternative smoking trend that’s taking over international markets might be more dangerous than tobacco companies are letting on—heat-not-burn tobacco’s negative impact on blood vessel function matches the damage done by smoking regular cigarettes, the American Heart Association reported at its Scientific Sessions 2017.

A simple, inexpensive tool could predict healthy individuals’ future risk of cardiovascular disease through just five painless calculations, Mount Sinai Health System reported today in a novel study. The paper was simultaneously published in the Journal of the American College of Cardiology.

The first microscopic video of a blood clot contraction is already changing the way scientists think about conditions like ischemic stroke, deep vein thrombosis and heart attacks, according to a Penn Medicine news story.

Black men are most likely to suffer from intracranial atherosclerotic disease (ICAD), an important contributor to stroke, while midlife risk factors for the illness vary between blacks and whites, according to a new study published in JAMA Cardiology.

Five-minute interventions, “quit kits” and information delivered by peers all proved to be successful strategies for getting through to young smokers, research out of the University of California-Davis reports.

A new lab technique could cut testing time and improve the accuracy of coronary artery disease (CAD) diagnoses, new research published in Radiology states.

College student Jillian Marks was taking a photo in a mirror at her East Northport, New York, home when she lost vision in her right eye.

A smoking trend that’s taken over Japan could soon be making its debut in the American market, possibly eclipsing the infamous e-cigarette as a more authentic alternative to traditional tobacco products.

Nearly half of patients failed to receive follow-up imaging within a year of vascular surgery, even if their hospitals participated in a national quality improvement registry, according to an analysis of Medicare beneficiaries.

Two decades after being approved by the FDA for treatment of acute ischemic stroke, clot-dissolving medication intravenous alteplase is administered to just 10 percent of patients, researchers from Georgia State recently reported in the American Journal of Emergency Medicine.

Physicians are aware of stroke risk factors at this point, but something is getting lost in translation.

Women have lower numbers of circulating progenitor cells, a study published in the Journal of the American Heart Association reported, possibly explaining the rise in adverse cardiovascular events in women after they reach menopause and start to age.